Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin Monotherapy as Third-Line Treatment for Metastatic Colorectal Cancer
NCT00017082Phase 2Completed
- Sponsor
- Prologue Research
- Start
- Apr 2001
- Primary completion
- Jun 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin in colorectal cancer (CRC), sponsored by Prologue Research. Primary endpoint: Overall Response Rate. Started Apr 2001; status: completed.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00017082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017082.